Career history of Hiroaki Shigeta
Former positions of Hiroaki Shigeta
| Companies | Position | Start | End |
|---|---|---|---|
| MEDICINOVA, INC. | Director/Board Member | 2009-09-15 | 2015-06-10 |
| Independent Dir/Board Member | 2009-09-13 | 2015-06-10 | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director/Board Member | 1993-09-30 | 2004-11-30 |
| Corporate Officer/Principal | 2002-12-31 | 2004-11-30 | |
| CHUGAI PHARMACEUTICAL CO., LTD | Director/Board Member | 2002-05-31 | 2003-03-31 |
Nippon Roche KK
 Nippon Roche KK Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Nippon Roche KK is a Japanese company that manufactures and sells pharmaceuticals. The company is based in Tokyo, Japan. Nippon Roche KK was acquired by Chugai Pharmaceutical Co., Ltd. from Roche Holding AG on October 01, 2002 for $1,613.74 million. | Chief Executive Officer | 1993-09-30 | 2000-11-30 |
| Chairman | 2000-12-31 | 2002-04-30 | |
| President | 1993-09-30 | 2000-11-30 | |
| THE MEDICINES COMPANY | Director/Board Member | 2007-04-08 | - |
| Independent Dir/Board Member | 2007-04-08 | - |
Training of Hiroaki Shigeta
| Momoyama Gakuin University | Undergraduate Degree |
| Haas School of Business | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Japan | 4 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MEDICINOVA, INC. | Health Technology |
| CHUGAI PHARMACEUTICAL CO., LTD | Health Technology |
| Private companies | 3 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Nippon Roche KK
Nippon Roche KK Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Nippon Roche KK is a Japanese company that manufactures and sells pharmaceuticals. The company is based in Tokyo, Japan. Nippon Roche KK was acquired by Chugai Pharmaceutical Co., Ltd. from Roche Holding AG on October 01, 2002 for $1,613.74 million. | Health Technology |
- Stock Market
- Insiders
- Hiroaki Shigeta
- Experience
